奥曲肽在老年肺结核大咯血的治疗价值探讨

The value of Octreotide in treating senile patients with severe hemoptysis of pulmonary tuberculosis

目的探讨奥曲肽在治疗老年肺结核大咯血的治疗价值。方法将69例老年人肺结核大咯血患者随机分为A、B两组,分别给予奥曲肽和脑垂体后叶素治疗,观察其疗效和不良反应。结果A﹑B两组总有效率分别为88.89%及69.69%,P<0.05。结论奥曲肽治疗老年肺结核大咯血疗效显著,副作用小,可作为治疗大咯血首选药物,值得临床推广应用。

Objective To discuss the value of Octreotide in treating senile patients with severe hemoptysis of pulmonary tuberculosis. Method All 69 ca-ses of senile patients with severe hemoptysis of pulmonary tuberculosis were divided into group A and B, and treated with Octreotide and Pituitrin respectively; effects and adverse reactions were researched. Result Effective rates of group A and B were 88.89% and 69.69% respectively; and there were significant difference between them in effects （P〈0.05）. Conelusion The Octreotide is the finest drug for treating senile patients with severe hemoptysis of pulmonary tuberculosis, and may be the first selected drug for patients with severse hemoptysis.